Portfolio monitoring, quarter after quarter.
Fund managers need defensible fair value for every position — not just at exit. Zimbs Valetex delivers ASC 820-aligned marks across your entire portfolio, with audit-ready documentation on a predictable quarterly cadence.
Fund Snapshot
$248.6M NAV
NAV · 8 quarters
32
Holdings
21.4%
Net IRR
2.1x
MOIC
Axiom Robotics
Series B
$9.8M
+12.4%
Nova Health
Series A
$3.1M
+2.1%
Lumen Data
Seed
$0.7M
-9.6%
Coverage across every asset class.
From early-stage equity to venture debt, every position in your fund is valued under a single, consistent, fully documented framework.
Equity Stakes
Common and preferred positions, calibrated to the latest round.
- OPM & PWERM backsolve
- Recent-round calibration
- Per-class allocation
Convertibles & SAFEs
Discount, cap, and conversion mechanics modeled to fair value.
- Discount & cap modeling
- Conversion scenarios
- As-converted marks
Debt & Credit
Venture debt and credit instruments held across the portfolio.
- Yield & spread analysis
- Impairment screening
- Accrued-interest marks
Warrants & Options
Coverage instruments priced with defensible option models.
- Black-Scholes pricing
- Coverage tracking
- Expiration auditing
The quarterly valuation cycle.
A repeatable six-step process that turns raw portfolio data into investor-ready fair value marks — the same way, every quarter.
Data Intake
Cap tables, financials, and round activity collected into one secure workspace.
Methodology Selection
Market, income, or transaction approach chosen and documented per holding.
Modeling & Marks
OPM, PWERM, and yield models run to a fully supported point estimate.
Internal Review
Second-reviewer sign-off on every input, assumption, and conclusion.
Valuation Memo
Each mark documented with support and a clear sensitivity analysis.
Investor Reporting
NAV roll-forward and per-holding fair value delivered to your LPs.
Built for fund reporting that holds up.
0+
Valuation methods in-house
OPM, PWERM, hybrid, backsolve, yield, Black-Scholes
0%
Audit defense rate
Marks sustained through Big 4 fieldwork
0 days
Quarter-close turnaround
From data lock to delivered marks
Audit-ready by default
Every mark ships with a memorandum your auditors can review without a follow-up.
Consistent, period over period
The same documented framework each quarter — marks stay comparable across time.
Analyst-led engagement
A dedicated credentialed analyst owns your portfolio from intake to investor report.
Every position, at a glance.
Current marks, the change since last quarter, and a full NAV roll-forward — the view your LPs and auditors expect.
Holdings Register
Q3 2025| Holding | Stage | Cost | Fair Value | Q/Q |
|---|---|---|---|---|
AXAxiom Robotics | Series B | $4.0M | $9.8M | +12.4% |
NVNova Health | Series A | $2.5M | $3.1M | +2.1% |
LMLumen Data | Seed | $1.0M | $0.7M | -9.6% |
NAV Roll-Forward
Sector Concentration
Frequently asked questions
We deliver fair value marks on a quarterly cadence aligned to your fund's reporting calendar, with interim valuations available for material events such as new financing rounds, down rounds, or exits.
Our coverage spans common and preferred equity stakes, convertible notes and SAFEs, venture debt and credit instruments, and warrants or options held across early-stage and growth-stage companies.
Yes. Every holding is valued under the ASC 820 fair value framework using a documented methodology — market, income, or recent-transaction approach — with a clear leveling assessment and an audit-ready support file.
We produce a complete valuation memorandum per holding covering methodology, inputs, and sensitivity analysis, formatted to withstand Big 4 audit scrutiny. We also coordinate directly with your audit team during fieldwork.
Modernize your portfolio marks.
Talk to our fund valuation specialists about a quarterly monitoring program tailored to your portfolio and reporting calendar.